TABLE II.
CHD Phenotype of Participants With CHD-Only, 22q-noCHD, and 22q-CHD
| CHD-only | 22q-noCHD | 22q-CHD | P-value | |
|---|---|---|---|---|
| CHD phenotype | 0.02 | |||
| Tetralogy of fallot (%) | 6 (38) | — | 7 (26) | |
| Interrupted aortic arch (%) | 1 (6) | — | 6 (22) | |
| Ventricular septal defect (%) | 9 (56) | — | 2 (7) | |
| Truncus arteriosus (%) | 0 | — | 5 (19) | |
| Patent ductus arteriosus (%) | 0 | — | 4 (15) | |
| Atrial septal defect (%) | 0 | — | 2 (7) | |
| Biscuspid aortic valve (%) | 0 | — | 1 (4) | |
| Other vascular anomaliesa | NS | |||
| yes (%) | — | 11 (40) | 19 (70) | |
| no (%) | — | 8 (30) | 5 (19) | |
| unknown (%) | 16 (100) | 8 (30) | 3 (11) | |
| CHD surgery (%) | 16 (100) | — | 21 (78) | NS |
P-values are determined by Fisher’s exact test. NS designates non-significance (P > 0.05).
a
Includes vascular ring, right aortic arch with mirror-image branching of brachiocephalic vessels, and aberrant origin subclavian artery.